A perspective current and past modes of inhalation therapy.

Autor: Canto Mangana J; Department of Biochemistry and Molecular Biology II, Pharmacy School, University of Granada, Granada, Spain.; Pharmacy Services, A.S. Hospital de Poniente de Almería, Almería, Spain., Schilder KA; Department of Biochemistry and Molecular Biology II, Pharmacy School, University of Granada, Granada, Spain., Bretones-Pedrinaci JI; Pharmacy Services, A.S. Hospital de Poniente de Almería, Almería, Spain., Blesa ARM; Department of Biochemistry and Molecular Biology II, Pharmacy School, University of Granada, Granada, Spain., de Medina FS; Department of Pharmacology, School of Pharmacy, University of Granada, Granada, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.; Instituto de Investigación Biosanitaria (IBS), Granada, Spain., Martínez-Augustin O; Department of Biochemistry and Molecular Biology II, Pharmacy School, University of Granada, Granada, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.; Instituto de Investigación Biosanitaria (IBS), Granada, Spain.; Institute of Nutrition and Food Technology 'José Mataix', Center of Biomedical Research, University of Granada, Granada, Spain., Daddaoua A; Department of Biochemistry and Molecular Biology II, Pharmacy School, University of Granada, Granada, Spain.; Instituto de Investigación Biosanitaria (IBS), Granada, Spain.; Institute of Nutrition and Food Technology 'José Mataix', Center of Biomedical Research, University of Granada, Granada, Spain.
Jazyk: angličtina
Zdroj: Microbial biotechnology [Microb Biotechnol] 2024 Feb; Vol. 17 (2), pp. e14419.
DOI: 10.1111/1751-7915.14419
Abstrakt: Inhalation is the preferred route of delivery for anti-asthma and chronic obstructive pulmonary disease (COPD) drugs. The use of this route has demonstrated efficacy in these and other conditions, it offers rapid onset of action, and is associated with minimal systemic exposure, thereby reducing the risk of adverse effects. Therefore, the current brief covers an interesting collection of inhaler action modes, shedding light on their molecular mechanisms and clinical applications for anti-asthma, COPD and antibacterial inhalation therapy. Hence, not only enriches our understanding of inhalation therapy molecular intricacies but also provides a comprehensive overview of the evolving landscape in clinical and antibacterial inhalation therapy. In doing so, it underscores the pivotal role of microbiology and biotechnology in advancing therapeutic approaches that harness the power of inhalation.
(© 2024 The Authors. Microbial Biotechnology published by Applied Microbiology International and John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje